![]() Out of all respondents, 269 (93.4%) assume that a VAT episode increases ICU length of stay, and this perception is greater in the LA group (97.3%) than in the SPF group (89.4%, P <0.05). Approximately half (50.3%) of the respondents agreed that patients should receive antibiotics for the treatment of VAT. The majority of respondents (n = 228 79.2%) reported making the diagnosis of VAT based on clinical and microbiological criteria, and 40 (13.9%) by clinical criteria alone. ResultsĪ total of 288 ICUs from 16 different countries answered the survey: 147 (51%) from the Latin American (LA) group and 141 (49%) from Spain, Portugal, and France (SPF group). ![]() We developed a questionnaire consisting of (a) characteristics of the respondent, the ICU, and hospital (b) current clinical and microbiological diagnostic approach (c) empirical antibiotic therapy and (d) the perception of physicians regarding the clinical impact of VAT and its implications. ![]() The objectives of this study were to survey reported practices in the clinical and microbiological diagnosis of VAT and to evaluate perceptions of the impact of VAT on patient outcomes. Several aspects of ventilator-associated tracheobronchitis (VAT)-including diagnostic criteria, overlap with ventilator-associated pneumonia (VAP), and appropriate treatment regimens-remain poorly defined. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |